BIAF (STOCKS)
bioAffinity Technologies, Inc. Common Stock
$2.815000
-0.365000 (-11.48%)
Prev close: $3.180000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Maria Zannes
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $12.66M
- Employees
- 57
- P/E (TTM)
- -0.21
- P/B (TTM)
- 1.97
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
0
Buy
3
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-4.74 | $-2.75 | -1.9860 | -72.11% |
|
Jun 2025 (Q2)
|
$-5.10 | $-3.06 | -2.0400 | -66.67% |
|
Mar 2025 (Q1)
|
$-4.80 | $-4.90 | +0.0960 | +1.96% |
|
Dec 2024 (Q4)
|
$-6.30 | $-4.28 | -2.0160 | -47.06% |
Financial Statements
| Revenues | $6.16M |
| Benefits Costs and Expenses | $21.03M |
| Costs And Expenses | $21.03M |
| Nonoperating Income/Loss | -$4.29M |
| Operating Expenses | $16.73M |
| Selling, General, and Administrative Expenses | $9.91M |
| Depreciation and Amortization | $504.84K |
| Research and Development | $1.38M |
| Other Operating Expenses | $4.93M |
| Operating Income/Loss | -$10.57M |
| Income/Loss From Continuing Operations After Tax | -$14.91M |
| Income/Loss From Continuing Operations Before Tax | -$14.87M |
| Income Tax Expense/Benefit | $44.04K |
| Income Tax Expense/Benefit, Current | $44.04K |
| Net Income/Loss | -$14.91M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$14.91M |
| Net Income/Loss Available To Common Stockholders, Basic | -$14.91M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$8.66 |
| Diluted Earnings Per Share | -$8.66 |
| Basic Average Shares | 1,721,082 |
| Diluted Average Shares | 1,721,082 |
| Assets | $10.96M |
| Current Assets | $7.57M |
| Inventory | $53.55K |
| Other Current Assets | $7.51M |
| Noncurrent Assets | $3.40M |
| Fixed Assets | $265.59K |
| Intangible Assets | $716.81K |
| Other Non-current Assets | $2.41M |
| Liabilities | $3.68M |
| Current Liabilities | $2.91M |
| Accounts Payable | $761.90K |
| Wages | $1.31M |
| Other Current Liabilities | $834.53K |
| Noncurrent Liabilities | $776.95K |
| Equity | $7.28M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $7.28M |
| Liabilities And Equity | $10.96M |
| Net Cash Flow From Operating Activities | -$9.33M |
| Net Cash Flow From Operating Activities, Continuing | -$9.33M |
| Net Cash Flow From Investing Activities | -$60.57K |
| Net Cash Flow From Investing Activities, Continuing | -$60.57K |
| Net Cash Flow From Financing Activities | $14.73M |
| Net Cash Flow From Financing Activities, Continuing | $14.73M |
| Net Cash Flow | $5.34M |
| Net Cash Flow, Continuing | $5.34M |
| Comprehensive Income/Loss | -$14.91M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$14.91M |
| Other Comprehensive Income/Loss | $0.00 |